1. Assessment of HER2 Protein Overexpression and Gene Amplification in Renal Collecting Duct Carcinoma: Therapeutic Implication
   Manuela Costantini et al, 2020, Cancers CrossRef
2. Comprehensive genomic profiling of metastatic collecting duct carcinoma, renal medullary carcinoma, and clear cell renal cell carcinoma
   Gennady Bratslavsky et al, 2021, Urologic Oncology: Seminars and Original Investigations CrossRef
3. Nivolumab and Ipilimumab Combination Immunotherapy for Patients with Metastatic Collecting Duct Carcinoma
   Tetsuya Danno et al, 2021, Case Reports in Urology CrossRef
4. Integrative Transcriptomic Analysis Reveals Distinctive Molecular Traits and Novel Subtypes of Collecting Duct Carcinoma
   Chiara Gargiuli et al, 2021, Cancers CrossRef
5. Immune checkpoint inhibitors in non-conventional histologies of renal-cell carcinoma
   Melissa Bersanelli et al, 2023, Human Vaccines & Immunotherapeutics CrossRef
6. Metastatic Renal Medullary and Collecting Duct Carcinoma in the Era of Antiangiogenic and Immune Checkpoint Inhibitors: A Multicentric Retrospective Study
   Zoé Guillaume et al, 2022, Cancers CrossRef
7. Complete response to combination therapy using nivolumab and ipilimumab for metastatic, sarcomatoid collecting duct carcinoma presenting with high expression of programmed death-ligand 1: a case report
   Takayoshi Fuu et al, 2022, Journal of Medical Case Reports CrossRef
8. Characteristics and Treatment Challenges of Non-Clear Cell Renal Cell Carcinoma
   Pierangela Sepe et al, 2021, Cancers CrossRef
9. Update in collecting duct carcinoma: Current aspects of the clinical and molecular characterization of an orphan disease
   Cristina Suarez et al, 2022, Frontiers in Oncology CrossRef